Keyword

CI-1040

Description: CI-1040 is an experimental anticancer drug that inhibits MEK enzymes in the MAPK signaling pathway.
Wikidata ID: wiki/Q27076005
OpenAlex ID: keywords/ci-1040
2005 · Patricia M. LoRusso, Alex A. Adjei, et al. · Journal of Clinical Oncology · 421
2008 · Stephen D. Barrett, Alexander J. Bridges, et al. · Bioorganic & Medicinal Chemistry Letters · 321
2003 · L ALLEN, Judith Sebolt-Leopold, et al. · Seminars in Oncology · 275
2009 · Jane J. Yu, Victoria A. Robb, et al. · Proceedings of the National Academy of Sciences · 167
2008 · Kwong-Kwok Wong · Recent Patents on Anti-Cancer Drug Discovery · 167
2008 · Robert A. Cartlidge, G. R. Thomas, et al. · Pigment Cell & Melanoma Research · 129
2008 · N Nakayama, K Nakayama, et al. · British Journal of Cancer · 125
2004 · Judith Sebolt-Leopold · Current Pharmaceutical Design · 125
2010 · Janos Groh, Kristina Heinl, et al. · Human Molecular Genetics · 94
2007 · Marie-Emmanuelle Legrier, Chia-Ping Huang Yang, et al. · Cancer Research · 94
2005 · Yuli Wangab, Keri Van Becelaere, et al. · Neoplasia · 58
Works count: 123
Citation count: 4,966
Year
Topic
Type